Cibc Private Wealth Group, LLC Guardant Health, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 67 shares of GH stock, worth $3,243. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67
Previous 244
72.54%
Holding current value
$3,243
Previous $7,000
71.43%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding GH
# of Institutions
393Shares Held
121MCall Options Held
1.43MPut Options Held
2.37M-
Vanguard Group Inc Valley Forge, PA12.1MShares$585 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$544 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$264 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$249 Million0.04% of portfolio
-
Baillie Gifford & CO5.06MShares$245 Million0.19% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.95B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...